Guardian Pharmacy Services (NYSE:GRDN – Get Free Report) and Profound Medical (NASDAQ:PROF – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.
Profitability
This table compares Guardian Pharmacy Services and Profound Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Guardian Pharmacy Services | -6.90% | -52.41% | -24.17% |
| Profound Medical | -343.97% | -89.74% | -73.06% |
Risk and Volatility
Guardian Pharmacy Services has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Comparatively, Profound Medical has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Guardian Pharmacy Services | 1 | 0 | 3 | 0 | 2.50 |
| Profound Medical | 1 | 0 | 1 | 0 | 2.00 |
Guardian Pharmacy Services currently has a consensus target price of $29.33, suggesting a potential upside of 1.96%. Profound Medical has a consensus target price of $11.00, suggesting a potential upside of 83.95%. Given Profound Medical’s higher possible upside, analysts plainly believe Profound Medical is more favorable than Guardian Pharmacy Services.
Valuation and Earnings
This table compares Guardian Pharmacy Services and Profound Medical”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Guardian Pharmacy Services | $1.33 billion | 1.37 | -$87.29 million | ($1.52) | -18.93 |
| Profound Medical | $11.84 million | 15.25 | -$27.82 million | ($1.46) | -4.10 |
Profound Medical has lower revenue, but higher earnings than Guardian Pharmacy Services. Guardian Pharmacy Services is trading at a lower price-to-earnings ratio than Profound Medical, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
47.9% of Profound Medical shares are held by institutional investors. 63.7% of Guardian Pharmacy Services shares are held by company insiders. Comparatively, 1.5% of Profound Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Summary
Guardian Pharmacy Services beats Profound Medical on 8 of the 14 factors compared between the two stocks.
About Guardian Pharmacy Services
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.
About Profound Medical
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.
Receive News & Ratings for Guardian Pharmacy Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardian Pharmacy Services and related companies with MarketBeat.com's FREE daily email newsletter.
